September 24, 2021

Targovax granted European Patent for ONCOS-102 in combination with chemotherapy

Patent protection of ONCOS-102 in combination with chemotherapy in malignant pleural mesothelioma in Europe  Oslo, 24 September 2021: Targovax ASA (OSE: TRVX), a clinical ...
Read more
September 23, 2021

Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.

DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced ...
Read more
September 22, 2021

CARISMA Therapeutics Announces U.S. Food and Drug Administration Grants Fast Track Designation to CT-0508 for the Treatment of Patients with Solid Tumors

PHILADELPHIA, Sept. 22, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative ...
Read more
September 22, 2021

Vicore obtains SARS coronavirus patent for C21 in the USA

Gothenburg, September 22, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders, t...
Read more
September 22, 2021

Vicore to host Key Opinion Leader webinar on C21 for the treatment of idiopathic pulmonary fibrosis (IPF)

Webinar on Thursday, September 30 @ 16:00 CET (10AM ET) with the medical doctors and IPF experts Prof. Toby Maher and Prof. Joanna Porter. Gothenburg, September 22, 2021 - Vicore ...
Read more
September 21, 2021

Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment

Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey Issue Coverage Policies Providing Coverage for Treatment with the Zephyr® Valve REDWOO...
Read more
September 21, 2021

Fusion Pharmaceuticals Appoints Eric S. Hoffman, Ph.D. As Senior Vice President, Business Development

HAMILTON, ON and BOSTON, Sept. 21, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing nex...
Read more
September 21, 2021

Hemab Appoints Mads Behrndt as Chief Financial Officer

Copenhagen, Denmark and Boston, US – 21 September 2021 Hemab ApS (“Hemab”), a biotech company developing next generation therapeutics for serious underserved bleeding and...
Read more
September 20, 2021

Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021

BOSTON, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing ...
Read more
September 17, 2021

Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3

Gothenburg, September 17, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for severe lung disorders to...
Read more
Older news →